Immunitas Therapeutics is a startup based in the United States, most recent round Series B, 1 tracked investor.
Immunitas Therapeutics is a startup founded in 2019 based in the United States. Its most recent tracked round is Series B. Brouky records 1 investor associated with the company.
Immunitas Therapeutics is a clinical-stage precision immunotherapy company committed to discovering and developing novel, differentiated antibody-based therapeutics for patients with cancer and autoimmune diseases, leveraging a specialized single-cell genomics platform to identify and validate immune targets.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.